Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: J Immunol. 2013 Aug 19;191(6):10.4049/jimmunol.1300967. doi: 10.4049/jimmunol.1300967

FIGURE 5. Similar CTL mediated killing responses in spleens of vaccinated BLT1+/+ or BLT1−/− animals.

FIGURE 5

The CTL in vivo killing assay was performed in groups of WT and BLT1−/−mice as described in methods. The mice were vaccinated with 50 μg of E749-57 peptide + 10 μg of MPL-A in 200 μl of PBS. A group of naïve mice was also used as control. (A). Representative histograms of CFSE labeled targets. The killing levels of target cells in WT and BLT1−/− mice immunized with the E749-57 peptide+ MPL-A vaccine as described in methods. Cumulative levels of killing activity (n=4) of peptide immunized (B). No functional defect was observed in killing activity of CTLs in BLT1−/− mice.